Aardvark Therapeutics, Inc. Common Stock Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| DECHENG CAPITAL LLC | 11/14/2025 | 3.92 M | $52.06 M | 0.00% | 18.06% |
| CITADEL ADVISORS LLC | 11/14/2025 | 1.36 M | $18.07 M | 5.93% | 6.27% |
| LAURION CAPITAL MANAGEMENT LP | 11/17/2025 | 1.05 M | $13.95 M | 6.13% | 4.84% |
| VANGUARD GROUP INC | 11/07/2025 | 555.72 K | $7.39 M | 20.55% | 2.56% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 350.00 K | $4.65 M | 100.00% | 1.61% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 319.62 K | $4.25 M | 100.00% | 1.47% |
| BLACKROCK, INC. | 11/12/2025 | 309.47 K | $4.11 M | 50.38% | 1.43% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/12/2025 | 306.91 K | $4.08 M | 7.01% | 1.42% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2025 | 253.75 K | $3.37 M | -9.13% | 1.17% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 194.04 K | $2.58 M | 41.71% | 0.89% |
| CRESSET ASSET MANAGEMENT, LLC | 11/12/2025 | 146.78 K | $1.95 M | 100.00% | 0.68% |
| CANTOR FITZGERALD, L. P. | 12/01/2025 | 96.68 K | $1.28 M | 26.08% | 0.45% |
| STATE STREET CORP | 11/14/2025 | 93.01 K | $1.24 M | 149.26% | 0.43% |
| MORGAN STANLEY | 11/14/2025 | 68.46 K | $909.86 K | 664.08% | 0.32% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 63.57 K | $844.83 K | 100.00% | 0.29% |
| NORTHERN TRUST CORP | 11/14/2025 | 57.20 K | $760.15 K | 26.86% | 0.26% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 56.55 K | $751.50 K | 59.31% | 0.26% |
| UBS GROUP AG | 11/13/2025 | 54.73 K | $727.34 K | 5.40% | 0.25% |
| BARCLAYS PLC | 11/12/2025 | 39.93 K | $530.62 K | -21.03% | 0.18% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 25.70 K | $341.55 K | 100.00% | 0.12% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 23.93 K | $318.03 K | 199.54% | 0.11% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 22.00 K | $292.38 K | 100.00% | 0.10% |
| JANE STREET GROUP, LLC | 11/14/2025 | 19.45 K | $258.45 K | 100.00% | 0.09% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 18.93 K | $251.54 K | 1.79% | 0.09% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 15.52 K | $206.30 K | 100.00% | 0.07% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 14.24 K | $189.25 K | 0.00% | 0.07% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 5.73 K | $76.09 K | 0.00% | 0.03% |
| RHUMBLINE ADVISERS | 11/06/2025 | 5.71 K | $75.81 K | 3.94% | 0.03% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 3.92 K | $52.06 K | 20.93% | 0.02% |
| NEW YORK STATE COMMON RETIREMENT FUND | 11/03/2025 | 3.82 K | $50.81 K | -47.63% | 0.02% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11/14/2025 | 2.59 K | $34.36 K | -16.37% | 0.01% |
| JPMORGAN CHASE & CO | 11/26/2025 | 2.32 K | $30.78 K | -13.49% | 0.01% |
| POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 11/12/2025 | 2.12 K | $28.18 K | 100.00% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 1.19 K | $15.75 K | -6.55% | 0.01% |
| STRS OHIO | 10/30/2025 | 1.10 K | $14.62 K | 0.00% | 0.01% |
| STONE HOUSE INVESTMENT MANAGEMENT, LLC | 10/27/2025 | 1.00 K | $13.29 K | 100.00% | 0.00% |
| LEGAL & GENERAL GROUP PLC | 11/13/2025 | 587 | $7.80 K | 0.00% | 0.00% |
| AMERITAS INVESTMENT PARTNERS, INC. | 11/10/2025 | 578 | $7.68 K | 0.00% | 0.00% |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2025 | 469 | $6.23 K | 100.00% | 0.00% |
| FMR LLC | 11/13/2025 | 363 | $4.82 K | 100.00% | 0.00% |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 11/14/2025 | 355 | $4.72 K | 0.28% | 0.00% |
| ROYAL BANK OF CANADA | 11/14/2025 | 305 | $4.00 K | 13.81% | 0.00% |
| AMALGAMATED BANK | 10/29/2025 | 193 | $3.00 K | 0.00% | 0.00% |
| STERLING CAPITAL MANAGEMENT LLC | 11/12/2025 | 182 | $2.42 K | 142.67% | 0.00% |
| CITIGROUP INC | 11/10/2025 | 167 | $2.22 K | -91.49% | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 11/07/2025 | 140 | $1.86 K | 100.00% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 11/10/2025 | 60 | $797 | 100.00% | 0.00% |
| SRS CAPITAL ADVISORS, INC. | 11/14/2025 | 21 | $280 | 100.00% | 0.00% |
| CORMORANT ASSET MANAGEMENT, LP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Aardvark Therapeutics, Inc. Common Stock institutional Ownership - FAQ's
During the previous two years, 49 institutional investors and hedge funds held shares of Aardvark Therapeutics, Inc. Common Stock. The most heavily invested institutionals were:
Decheng Capital LLC: 3.92 M
CITADEL ADVISORS LLC: 1.36 M
Laurion Capital Management LP: 1.05 M
VANGUARD GROUP INC: 555,721
ADAGE CAPITAL PARTNERS GP, L.L.C.: 350,000
MILLENNIUM MANAGEMENT LLC: 319,623
43.64% of Aardvark Therapeutics, Inc. Common Stock stock is owned by institutional investors.
Institutional investors have bought a total of 9.47 M shares in the last 24 months. This purchase volume represents approximately $117.38 M in transactions.